The group's principle activity is to provide clinical research management services. The group also provides study designing, site initiation, project management, monitoring, pharma co-vigilance, data management, bio-statistical analyses, and medical writing services. The group's services include pre-clinical toxicology and pharmacology review, protocol writing, and support services. The group operates from United States.
Executive Information
Name
Title
Email
Michael O'Brien
CEO, Pres.
N/A
Steven Trigilio
CTO
N/A
Art Gertel
VP - Clinical Services
N/A
Donna Beardsworth
Exec. VP, Chief Delivery Officer
N/A
Linda Diehl Martz
Project Dir. - Beardsworth, Exec. Dir. - Data Management
